WuXi AppTec Group and Mayo Clinic Receive 2018 MedTech Insight Award for Best Alliance

WuXi Diagnostics, a joint venture between WuXi AppTec Group (“WuXi AppTec”) and Mayo Clinic, recently received the 2018 MedTech Insight Award for the Best Alliance. The company received the award on September 26 in Philadelphia at the MedTech Conference, a premier annual gathering for the medical technology industry.

The In Vivo Award for Best MedTech Alliance honors two or more organizations whose joint activity sets a new benchmark in health care. The partnership could involve multiple medical technology companies or pharmaceutical firms, or it could include a medical technology company and a contract research organization, research institute, not-for-profit, or cooperative group.

WuXi Diagnostics is a strategic collaboration between WuXi AppTec Group and Mayo Clinic. The joint venture is developing an open-technology platform, which enables scientists to commercialize innovative ideas into cutting-edge clinical tests for complex diseases. The company will build a medical databank based on its two enabling platforms and educate health care providers across all levels of hospitals. WuXi Diagnostics will accelerate the development of esoteric tests that both organizations will offer in their respective markets with the intent to benefit not only patients in China but around the world.

“We are pleased to receive this award. This joint venture is at a very early stage and is growing rapidly. Our vision is to ensure every disease can be precisely diagnosed.” says Jason Liu, Ph.D., General Manager of WuXi Diagnostics. “With support from two great organizations—WuXi AppTec Group and Mayo Clinic—we are confident that WuXi Diagnostics will achieve its vision, enable doctors to make better diagnoses for their patients, elevate a hospital’s disease-management program, and accelerate innovation for the clinical diagnostics industry. Together, we want to bring the best testing solutions from research to the clinical practice.”

“Mayo Clinic is honored to receive this award from MedTech,” says William Morice, II, M.D., Ph.D., President of Mayo Medical Laboratories and Chair of Laboratory Medicine and Pathology at Mayo Clinic. “WuXi AppTec Group has a deep understanding of the Chinese market, rich resources to support this joint venture, and the ability to execute. We are pleased to have this strong collaboration in China to accelerate diagnostic research into tests that will help patients all over the world.”

Mayo Clinic’s joint venture with WuXi Diagnostics concluded in early February 2024.

Gina Chiri-Osmond

Gina Chiri-Osmond is a Marketing Channel Manager at Mayo Clinic Laboratories.